Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan-Hee Lee

Showing results (221-230 of 223) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 223 results.
Heart, Lung & Circulation|October 5, 2020
Clinical Implication of 'Obesity Paradox' in Elderly Patients With Acute Myocardial InfarctionHun-Tae Kim, Sung-Yun Jung, Jong-Ho Nam, et al.
Frontiers in Cardiovascular Medicine|December 6, 2024
Beta-blockers after percutaneous coronary intervention for acute myocardial infarction and non-reduced left ventricular ejection fractionJun-Chang Jeong, Jong-Il Park, Byung-Jun Kim, et al.
Journal of Korean Medical Science|November 23, 2013
A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE studyUng Kim, Chan-Hee Lee, Jung-Hwan Jo, et al.
Pageof 23

Showing results (221-230 of 223) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 223 results.
Heart, Lung & Circulation|October 5, 2020
Clinical Implication of 'Obesity Paradox' in Elderly Patients With Acute Myocardial InfarctionHun-Tae Kim, Sung-Yun Jung, Jong-Ho Nam, et al.
Frontiers in Cardiovascular Medicine|December 6, 2024
Beta-blockers after percutaneous coronary intervention for acute myocardial infarction and non-reduced left ventricular ejection fractionJun-Chang Jeong, Jong-Il Park, Byung-Jun Kim, et al.
Journal of Korean Medical Science|November 23, 2013
A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE studyUng Kim, Chan-Hee Lee, Jung-Hwan Jo, et al.
Pageof 23